President Donald Trump has nominated Dr. Erica Schwartz to serve as the next director of the Centers for Disease Control and Prevention (CDC).
The move comes after months of instability and leadership turnover at the nation’s top public health agency.
The announcement, made Thursday, April 16, 2026, via Trump’s Truth Social platform, marks a significant shift in the administration’s effort to restore continuity at the CDC, which has struggled to maintain a Senate-confirmed director during Trump’s second term.
“It is my Honor to nominate the incredibly talented Dr. Erica Schwartz… She is a STAR!” Trump wrote.
Dr Schwartz has extensive background in medicine, law, and public health, as well as her prior service as Deputy Surgeon General during his first administration.
A Leadership Vacuum at the CDC
Schwartz’s nomination follows a prolonged period of uncertainty at the CDC. The agency has been without a permanent leader for months, with its most recent director, Susan Monarez, serving for less than one month before being removed amid internal disputes.
During the interim, oversight of the agency fell to Jay Bhattacharya, director of the National Institutes of Health, underscoring the unusual leadership arrangement at a time of major public health policy shifts.
The turbulence has been closely tied to broader changes led by Health and Human Services Secretary Robert F. Kennedy Jr., whose tenure has included restructuring efforts, workforce reductions, and controversial revisions to U.S. vaccine policy—some of which have been challenged in court.
Schwartz’s Background and Qualifications
Dr. Schwartz brings a multifaceted résumé to the role. A rear admiral in the U.S. Coast Guard and a longtime member of the U.S. Public Health Service Commissioned Corps, she served for more than two decades in federal health leadership roles.
She holds degrees in medicine, law, and public health, including a medical degree from Brown University and a law degree from the University of Maryland. Her experience spans military medicine, federal health policy, and executive leadership within the government.
Notably, Schwartz was not selected to serve as acting U.S. Surgeon General under former President Joe Biden, a decision that effectively sidelined her from federal leadership until her return under Trump’s second administration.
Broader Health Leadership Reshuffle
Alongside Schwartz’s nomination, Trump unveiled a broader restructuring of top health leadership positions. Healthcare executive Sean Slovenski has been named CDC Chief Operating Officer, while Dr. Jennifer Shuford will serve as Chief Medical Director.
Additionally, Dr. Sara Brenner has been appointed Senior Counselor for Public Health, working closely with federal health agencies and supporting Kennedy’s policy agenda.
Political and Public Health Implications
Schwartz’s nomination arrives at a critical moment for the CDC, as it navigates both internal restructuring and external scrutiny over public health decision-making. The agency has faced criticism from scientists and former officials who argue that recent policy changes, particularly around vaccines, have undermined public trust.
Earlier this year, a federal judge blocked several proposed vaccine policy changes, highlighting the legal and scientific tensions surrounding the agency’s direction.
If confirmed, Schwartz will be tasked with stabilizing the CDC’s leadership, rebuilding institutional credibility, and guiding national responses to ongoing and emerging public health challenges.
Her appointment also signals a return of a trusted figure from Trump’s first administration, one who now steps into a role shaped by political contention, scientific debate, and heightened public expectations.
